Physician
Hematology & Oncology
Hematology & Oncology
ARCADIA, CA
Based on specialty. Actual services may vary — contact the provider's office to confirm.
MIPS (Merit-based Incentive Payment System) scores measure quality, cost, and improvement activities. Higher is better. Learn more at qpp.cms.gov
Based on CMS Medicare Provider Utilization data for 2023. These represent what this physician charged Medicare, not necessarily what you would pay. Compare with other physicians
| Procedure | Avg Charge | Medicare Allowed | Medicare Paid | Services |
|---|---|---|---|---|
99205 New patient office or other outpatient visit, 60-74 minutes | $821 | $233 | $181 | 66 |
99215 Established patient office or other outpatient visit, 40-54 minutes | $672 | $191 | $144 | 223 |
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | $632 | $182 | $144 | 122 |
J9217 Leuprolide acetate (for depot suspension), 7.5 mg | $613 | $172 | $136 | 168 |
96413 Administration of chemotherapy into vein, 1 hour or less | $606 | $152 | $121 | 347 |
99214 Established patient office or other outpatient visit, 30-39 minutes | $481 | $137 | $105 | 847 |
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | $448 | $195 | $156 | 65 |
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | $431 | $125 | $99 | 549 |
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | $390 | $110 | $87 | 564 |
99213 Established patient office or other outpatient visit, 20-29 minutes | $341 | $94 | $57 | 12 |
99442 Telephone medical discussion with physician, 11-20 minutes | $341 | $71 | $54 | 24 |
99497 Advance care planning, first 30 minutes | $306 | $87 | $67 | 45 |
96417 Administration of additional new drug or substance into vein, 1 hour or less | $295 | $74 | $59 | 123 |
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | $269 | $74 | $54 | 49 |
96411 Administration of additional new drug or substance into vein using push technique | $247 | $64 | $51 | 45 |
96360 Infusion into a vein for hydration, 31-60 minutes | $220 | $37 | $29 | 61 |
96374 Injection of drug or substance into vein | $200 | $43 | $34 | 18 |
J9271 Injection, pembrolizumab, 1 mg | $192 | $54 | $43 | 11,200 |
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | $147 | $33 | $26 | 115 |
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | $134 | $39 | $31 | 69 |
96415 Administration of chemotherapy into vein, each additional hour | $134 | $32 | $26 | 129 |
36591 Collection of blood sample from implanted device | $109 | $31 | $25 | 76 |
J9299 Injection, nivolumab, 1 mg | $106 | $30 | $24 | 21,000 |
96523 Irrigation of implanted venous access drug delivery device | $103 | $30 | $23 | 33 |
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | $101 | $28 | $22 | 2,615 |
96375 Injection of additional new drug or substance into vein | $93 | $17 | $14 | 486 |
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | $88 | $23 | $18 | 40 |
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | $84 | $22 | $18 | 64 |
J0897 Injection, denosumab, 1 mg | $83 | $23 | $18 | 14,100 |
96377 Application of on-body injector for under skin injection | $81 | $21 | $17 | 15 |
96372 Injection of drug or substance under skin or into muscle | $81 | $16 | $12 | 317 |
96361 Infusion into a vein for hydration, each additional hour | $69 | $14 | $11 | 71 |
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg | $62 | $17 | $14 | 19 |
J3489 Injection, zoledronic acid, 1 mg | $32 | $9 | $5 | 69 |
J3490 Unclassified drugs | $23 | $1 | $1 | 84 |
J0640 Injection, leucovorin calcium, per 50 mg | $14 | $4 | $3 | 913 |
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | $11 | $3 | $2 | 27,100 |
J0780 Injection, prochlorperazine, up to 10 mg | $10 | $3 | $2 | 17 |
J9045 Injection, carboplatin, 50 mg | $9 | $2 | $2 | 188 |
J9190 Injection, fluorouracil, 500 mg | $8 | $2 | $2 | 625 |
J9206 Injection, irinotecan, 20 mg | $8 | $2 | $2 | 546 |
J0185 Injection, aprepitant, 1 mg | $6 | $2 | $1 | 15,080 |
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | $5 | $1 | $1 | 35 |
J1439 Injection, ferric carboxymaltose, 1 mg | $4 | $1 | $1 | 15,000 |
J1200 Injection, diphenhydramine hcl, up to 50 mg | $4 | $1 | $1 | 79 |
J9267 Injection, paclitaxel, 1 mg | $0 | $0 | $0 | 3,072 |
J1100 Injection, dexamethasone sodium phosphate, 1 mg | $0 | $0 | $0 | 1,786 |
J2405 Injection, ondansetron hydrochloride, per 1 mg | $0 | $0 | $0 | 1,992 |
J0461 Injection, atropine sulfate, 0.01 mg | $0 | $0 | $0 | 1,840 |
J9263 Injection, oxaliplatin, 0.5 mg | $0 | $0 | $0 | 17,980 |
Search published hospital rates side by side to find lower cash prices and stronger negotiating leverage.
Physician identity data from the NPPES NPI Registry. Last synced 3/28/2026.